These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 21211404)

  • 1. [Difference of immunological and inflammatory indices between mild type and severe type of adult pandemic (H1N1) patients].
    Fan R; He J; Zhang X; Jiang TJ; Xie YX; Zhou ZP; Yan HY; Li WG; Tu B; Zhao M
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(41):2947-8. PubMed ID: 21211404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes and analysis of peripheral white blood cells and lymphocyte subsets for patients with pandemic influenza A virus (H1N1) infection].
    Chen WW; Xie YX; Zhang YH; Feng YQ; Li BA; Li B; Hong W; Liu J; Ma HB; Zhao M; Mao YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):331-3. PubMed ID: 21280315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients.
    Chen HX; Chen BG; Shi WW; Zhen R; Xu DP; Lin A; Yan WH
    Hum Immunol; 2011 Feb; 72(2):159-65. PubMed ID: 21087648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus.
    Richards KA; Topham D; Chaves FA; Sant AJ
    J Immunol; 2010 Nov; 185(9):4998-5002. PubMed ID: 20889549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, treatments and prognosis of the initial cases of pandemic influenza H1N1 2009 virus infection in Shanghai China.
    Mu YP; Zhang ZY; Chen XR; Xi XH; Lu YF; Tang YW; Lu HZ
    QJM; 2010 May; 103(5):311-7. PubMed ID: 20185534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytopenia as a marker for pandemic influenza A/H1N1 2009 virus infection in children.
    Chiappini E; Galli L; Azzi A; Resti M; Bonsignori F; de Martino M
    J Med Virol; 2011 Jan; 83(1):1-4. PubMed ID: 21108332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia.
    Lee N; Chan PK; Wong CK; Wong KT; Choi KW; Joynt GM; Lam P; Chan MC; Wong BC; Lui GC; Sin WW; Wong RY; Lam WY; Yeung AC; Leung TF; So HY; Yu AW; Sung JJ; Hui DS
    Antivir Ther; 2011; 16(2):237-47. PubMed ID: 21447873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.
    Mak GC; Choy PW; Lee WY; Wong AH; Ng KC; Lim W
    J Med Virol; 2010 Nov; 82(11):1809-15. PubMed ID: 20872705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course.
    Agrati C; Gioia C; Lalle E; Cimini E; Castilletti C; Armignacco O; Lauria FN; Ferraro F; Antonini M; Ippolito G; Capobianchi MR; Martini F
    J Infect Dis; 2010 Sep; 202(5):681-9. PubMed ID: 20670171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological survey of 2009 H1N1 influenza in residents of Beijing, China.
    Deng Y; Pang XH; Yang P; Shi WX; Tian LL; Liu BW; Li S; Cui SJ; Li Y; Lu GL; Zhang L; Zhang X; Liu B; Seale H; Huang F; Wang QY
    Epidemiol Infect; 2011 Jan; 139(1):52-8. PubMed ID: 20854713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.
    Loebermann M; Anders G; Brestrich G; Fritzsche C; Klammt S; Boršo D; Frimmel S; Riebold D; Reisinger EC
    Vaccine; 2011 Feb; 29(6):1228-34. PubMed ID: 21167116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
    N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalized patients with novel influenza A (H1N1) virus infection: Shanghai, June - July 2009.
    Xiao H; Lu SH; Ou Q; Chen YY; Huang SP
    Chin Med J (Engl); 2010 Feb; 123(4):401-5. PubMed ID: 20193477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative lymphopenia and monocytosis may be considered as a surrogate marker of pandemic influenza a (H1N1).
    Coşkun O; Avci IY; Sener K; Yaman H; Ogur R; Bodur H; Eyigün CP
    J Clin Virol; 2010 Apr; 47(4):388-9. PubMed ID: 20133186
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(44):1241-5. PubMed ID: 19910912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcomes of severe pandemic influenza A/H1N1/2009].
    Klimova EA; Iushchuk ND; Karetkina GN; Boĭtsov PV; Serobian AG; Kelli EI; Malyshev NA; Golokhvastova NO; Esaulova MR; Karchevskaia NA; Avdeev SN
    Ter Arkh; 2010; 82(11):15-8. PubMed ID: 21381342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination.
    Subbramanian RA; Basha S; Shata MT; Brady RC; Bernstein DI
    Vaccine; 2010 Dec; 28(52):8258-67. PubMed ID: 21050903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
    Esposito S; Tagliaferri L; Daleno C; Valzano A; Picciolli I; Tel F; Prunotto G; Serra D; Galeone C; Plebani A; Principi N
    Vaccine; 2011 Feb; 29(8):1677-82. PubMed ID: 21199699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009.
    Grills N; Piers LS; Barr I; Vaughan LM; Lester R; Magliano DJ; Shaw JE; Carnie JA
    Aust N Z J Public Health; 2010 Jun; 34(3):228-31. PubMed ID: 20618261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes in magnitude and diversity of cross-reactive CD4+ T-cell responses to the novel pandemic H1N1 influenza hemagglutinin.
    Subbramanian RA; Basha S; Brady RC; Hazenfeld S; Shata MT; Bernstein DI
    Hum Immunol; 2010 Oct; 71(10):957-63. PubMed ID: 20650295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.